Mycobacterium tuberculosis bacteria

AUTHORS

Lúcia Moreira-Teixeira, Philippa J. Stimpson, Evangelos Stavropoulos, Sabelo Hadebe, Probir Chakravarty, Marianna Ioannou, Iker Valle Aramburu, Eleanor Herbert, Simon L. Priestnall, Alejandro Suarez-Bonnet, Jeremy Sousa, Kaori L. Fonseca, Qian Wang, Sergo Vashakidze, Paula Rodríguez-Martínez, Cristina Vilaplana, Margarida Saraiva, Venizelos Papayannopoulos & Anne O'Garra

 

SUMMARY

Tuberculosis (TB) is a leading cause of mortality due to infectious disease, but the factors determining disease progression are unclear. Transcriptional signatures associated with type I IFN signaling and neutrophilic inflammation were shown to correlate with disease severity in mouse models of TB. Here we show that similar transcriptional signatures correlate with increased bacterial loads and exacerbate pathology during Mycobacterium tuberculosis infection upon GM-CSF blockade. Loss of GM-CSF signaling or genetic susceptibility to TB (C3HeB/FeJ mice) result in type I IFN-induced neutrophil extracellular trap (NET) formation that promotes bacterial growth and promotes disease severity. Consistently, NETs are present in necrotic lung lesions of TB patients responding poorly to antibiotic therapy, supporting the role of NETs in a late stage of TB pathogenesis. Our findings reveal an important cytokine-based innate immune effector network with a central role in determining the outcome of M. tuberculosis infection.

 

REFERENCES

Lúcia Moreira-Teixeira et al. Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nature Communications volume 11, Article number: 5566 (2020). https://doi.org/10.1038/s41467-020-19412-6

PRODUCT HIGHLIGHTS

The following Bio X Cell in vivo grade monoclonal antibodies were featured in the publication:

The Bio X Cell Singapore website will permanently redirect to https://bioxcell.com/ from 30th April 2026.

This transition is designed to streamline access to new products, product data, technical resources, and provide a smoother ordering experience through our unified global platform.

All products, documentation, and customer support will continue to be available at: https://bioxcell.com/

https://bxcell.sg/ will remain active temporarily to support this transition before redirecting automatically.

Please update your bookmarks to https://bioxcell.com/.

For regional support, please refer to https://bioxcell.com/our-distributors.

For Singapore customers, please contact our authorized distributor, Omnicell Pte Ltd:-

eMail : enquiry@omnicell.com.sg ; Tel : 67470201

Website : www.omnicell.com.sgĀ 

Do not show this again [ CLOSE ]